Exchange: NYSEArca·Updated 03:52 PM EDT

IJH News

News
all
press releases
HIMS Stock Gains As Company Enters German Men’s Weight Market As Investors Watch US Peptide Compounding Policy
Hims is introducing online weight-management care for men in Germany, beginning with private consultations that can lead to prescriptions from EU-licensed clinicians.
Stocktwits
HIMS Stock Gains As Company Enters German Men’s Weight Market As Investors Watch US Peptide Compounding Policy
Hims is introducing online weight-management care for men in Germany, beginning with private consultations that can lead to prescriptions from EU-licensed clinicians.
Stocktwits
More News
Noteworthy ETF Outflows: IJH, OKTA, NVT, MTSI
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Mid-Cap ETF (Symbol: IJH) where we have detected an approximate $135.1 million dollar outflow -- that's a 0.1% decrease week ov...
Nasdaq News: Markets
GME Rises After Hours As Ryan Cohen Buys Another 844K Shares Worth Near $23M
Cohen acquired 67,130 shares at $26.75 apiece and another 777,000 shares at $27, according to a filing with the Securities and Exchange Commission.
Stocktwits
IJH, TWLO, OKTA, FTI: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Mid-Cap ETF (Symbol: IJH) where we have detected an approximate $967.1 million dollar outflow -- that's a 0.8% decrease week ov...
Nasdaq News: Markets
Should iShares Core S&P Mid-Cap ETF (IJH) Be on Your Investing Radar?
Style Box ETF report for IJH
Zacks
GME Pops 3% After the Bell As CEO Buys $26M Worth of Shares
According to a filing with the Securities and Exchange Commission on Monday, Cohen bought 1.15 million GME shares in multiple transactions priced between $22.76 and $23.02 for roughly $26.4 million.
Stocktwits
Not A ‘Gangbusters Launch’ — Arrowhead Predicts Slow Burn to $3B-$4B Peak For Redemplo, Highlights ‘Massive Pipeline’
Redemplo is already approved by the U.S. Food and Drug Administration (FDA) to lower very high triglycerides in the rare condition familial chylomicronemia syndrome.
Stocktwits
CELH Ticks Up After-Hours As Director DeSantis Follows CEO With $1M Buy
DeSantis, an independent director and son of late Celsius backer Carl DeSantis, purchased 20,000 shares on Monday at a weighted average of $27.65 and another 16,000 on Tuesday at $27.95.
Stocktwits
ARWR Stock Heads For Worst Day In Over A Year Despite Positive Cholesterol Drug Data — Is This A ‘Sell The News’ Move?
ARWR had already run hard into the catalyst and remains far above last year’s levels after a 52-week high near $95 in July.
Stocktwits
EXEL Stock Slides After FDA Adds Three Months To Cancer Drug Review — William Blair Sees More Swings In Near Term
The FDA told Exelixis on Thursday that it had extended the review of a new drug application for zanzalintinib plus Roche’s Tecentriq in patients whose colorectal cancer has spread.
Stocktwits

Advertisement|Remove ads.